Hello...there is a FDA approved drug called flavocoxid that Dr. Guiseppe Vita in Italy just completed a pilot study on with 20 duchenne boys. The results seem to be promising but I did not buy the full paper. Has anyone heard about this or have any additional information they could provide?
Tags:
Further data is being released by the end of February at the Italian Parent Project annual conference. I've got a copy of a poster produced by the team in Italy if you are interested - please email me at mark.silverman@actionduchenne.org
I would like to know if you have any update on a clinical trial testing Flavocoxid in Duchenne Muscular Dystrophy in Italy.
The trial was completed,but no updates.
This drug looks promising. Waiting for the updates.
I received this e.mail from the company which produces Limbrel (Flavocoxid) the results were disappointing:
The study to which you refer was initiated after some positive results were obtained in a mouse model of muscular dystrophy. The human trial was done in a small number of children and, while there were some suggestion of benefit, the results were overall disappointing. The investigators are considering whether to attempt a larger trial but, given the lack of a strong positive indicator, they are reluctant to embark on a larger trial.
Regards,
Robert M. Levy, MD
Primus Pharmaceuticals, Inc.
7373 N. Scottsdale Rd.
Ste B-200
Scottdale, AZ 85253
Tel: 480-483-1410
Cell: 480-415-6779
Fax: 480-483-2604
rlevy@primusrx.com
© 2021 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service